Defining outcomes for -cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop

Author(s):
Rickels, M.R.; Stock, P.G.; Koning, E.J.P. de (0000-0002-1232-7022); Piemonti, L.; Pratschke, J.; Alejandro, R.; Bellin, M.D.; Berney, T.; Choudhary, P.; Johnson, P.R.; Kandaswamy, R.; Kay, T.W.H.; Keymeulen, B.; Kudva, Y.C.; Latres, E.; Langer, R.M.; Lehmann, R.; Ludwig, B.; Markmann, J.F.; Marinac, M.; Odorico, J.S.; Pattou, F.; Senior, P.A.; Shaw, J.A.M.; Vantyghem, M.C.; White, S.
Published
2018
Publication type
Article / Letter to editor
Outcomeislet clinicalpancreas clinical
Date issued
2018-04-30
Language
English
Is part of
Transplant International (2018), Vol. 31, no. 4, p. 343-352
hdl
1887/86704
doi
10.1111/tri.13138